Anti-CHIC2/ BTL monoclonal antibody

Anti-CHIC2/ BTL antibody for FACS & in-vivo assay

Target products collectionGo to CHIC2/CHIC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0258-Ab-1/ GM-Tg-hg-MP0258-Ab-2Anti-Human CHIC2 monoclonal antibodyHuman
GM-Tg-rg-MP0258-Ab-1/ GM-Tg-rg-MP0258-Ab-2Anti-Rat CHIC2 monoclonal antibodyRat
GM-Tg-mg-MP0258-Ab-1/ GM-Tg-mg-MP0258-Ab-2Anti-Mouse CHIC2 monoclonal antibodyMouse
GM-Tg-cynog-MP0258-Ab-1/ GM-Tg-cynog-MP0258-Ab-2Anti-Cynomolgus/ Rhesus macaque CHIC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0258-Ab-1/ GM-Tg-felg-MP0258-Ab-2Anti-Feline CHIC2 monoclonal antibodyFeline
GM-Tg-cang-MP0258-Ab-1/ GM-Tg-cang-MP0258-Ab-2Anti-Canine CHIC2 monoclonal antibodyCanine
GM-Tg-bovg-MP0258-Ab-1/ GM-Tg-bovg-MP0258-Ab-2Anti-Bovine CHIC2 monoclonal antibodyBovine
GM-Tg-equg-MP0258-Ab-1/ GM-Tg-equg-MP0258-Ab-2Anti-Equine CHIC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0258-Ab-1/ GM-Tg-hg-MP0258-Ab-2; GM-Tg-rg-MP0258-Ab-1/ GM-Tg-rg-MP0258-Ab-2;
GM-Tg-mg-MP0258-Ab-1/ GM-Tg-mg-MP0258-Ab-2; GM-Tg-cynog-MP0258-Ab-1/ GM-Tg-cynog-MP0258-Ab-2;
GM-Tg-felg-MP0258-Ab-1/ GM-Tg-felg-MP0258-Ab-2; GM-Tg-cang-MP0258-Ab-1/ GM-Tg-cang-MP0258-Ab-2;
GM-Tg-bovg-MP0258-Ab-1/ GM-Tg-bovg-MP0258-Ab-2; GM-Tg-equg-MP0258-Ab-1/ GM-Tg-equg-MP0258-Ab-2
Products NameAnti-CHIC2 monoclonal antibody
Formatmab
Target NameCHIC2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHIC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CHIC2/ BTL VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002437human CHIC2 Lentivirus particle
    ORF Viral VectorpGMLP002437human CHIC2 Lentivirus plasmid
    ORF Viral VectorpGMLPm000749mouse Chic2 Lentivirus plasmid
    ORF Viral VectorvGMLPm000749mouse Chic2 Lentivirus particle


    Target information

    Target IDGM-MP0258
    Target NameCHIC2
    Gene ID26511,74277,83835,697359,100856618,101091277,615190,100054052
    Gene Symbol and Synonyms1700081B18Rik,4930502K01Rik,BTL,CHIC2
    Uniprot AccessionQ9UKJ5
    Uniprot Entry NameCHIC2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000109220
    Target ClassificationTumor-associated antigen (TAA)

    The target: CHIC2, gene name: CHIC2, also named as BTL. This gene encodes a member of the CHIC family of proteins. The encoded protein contains a cysteine-rich hydrophobic (CHIC) motif, and is localized to vesicular structures and the plasma membrane. This gene is associated with some cases of acute myeloid leukemia. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.